The Broad Institute, Inc Patent Portfolio Statistics

tip_user1

The Broad Institute, Inc.

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of The Broad Institute, Inc. look like?

Assignee Art Units
Total Applications: 528 1,004,756
Granted Patents: 151 399,935
Grant Index 69.59% ↑ 60.77%
Abandoned/Rejected Applications: 66 (30.41%) 258,218 (39.23%)
In-Process Applications: 304 346,603
Average Grant Time: 2.86 Years ↓ 2.94 Years
Average Office Actions: 2.17 ↑ 1.82

Which Technology Area The Broad Institute, Inc. is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 119
1636 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 77
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 37
1639 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 21
1637 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 18

How many patents are The Broad Institute, Inc. filing every year?

Year Total Applications Predicted
2022 0* 314
2021 70* 289
2020 92 361
2019 90 90
2018 60 –
2017 57 –
2016 32 –
2015 47 –
2014 31 –
2013 28 –

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of The Broad Institute, Inc. in USPTO?

Publication number: US20220228150A1
Application number: 17/616,621

Abstract:
High throughput methods utilizing spatially segregated detection systems provide a robust CRISPR-based diagnostic enabling highly sensitive detection of both DNA and RNA target molecules, with applications in multiple scenarios in human health including, for example, viral detection. Kits comprising the systems allow for point-of care applications with high-throughput processing of samples.

Publication date: –
Applicant: The Broad Institute, Inc.
Inventors: Deborah Hung

Publication number: US20220235322A1
Application number: 17/615,579

Abstract:
The present disclosure is directed to methods of producing dorsal forebrain organoids having cores with a very low incident of apoptotic and hypoxic cells and having highly similar cell types and cell type prevalence. The present disclosure is also directed to compositions comprising such organoids and the use of such organoids for the screening of agents.

Publication date: –
Applicant: The Broad Institute, Inc.
Inventors: Silvia Velasco

Publication number: US20220220469A1
Application number: 17/612,245

Abstract:
Described herein are non-Class I engineered CRISPR-Cas systems and components thereof, formulations thereof, cells thereof, and organisms thereof. Methods of making and using the CRISPR-Cas system described herein.

Publication date: –
Applicant: The Broad Institute, Inc.
Inventors: Altae-Tran Han

How are The Broad Institute, Inc.’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/616,621 Crispr System High Throughput Diagnostic Systems And Methods Application Dispatched from Preexam, Not Yet Docketed 1636 –
17/615,579 Reproducible Brain Organoids And Methods Of Making Application Dispatched from Preexam, Not Yet Docketed 1653 –
17/612,245 Non-Class I Multi-Component Nucleic Acid Targeting Systems Application Undergoing Preexam Processing 1642 –
17/530,402 Compositions And Methods For Cancer Expressing Pde3A Or Slfn12 Docketed New Case – Ready for Examination OPAP Central, Docket
17/612,019 Methods Of Preparing Macrocyclic Indoles Application Undergoing Preexam Processing 1629 –